Summit Global Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,845
Closed -$746K 554
2026
Q1
$746K Sell
53,845
-10,214
-16% -$142K 0.04% 255
2025
Q4
$899K Sell
64,059
-60,305
-48% -$846K 0.05% 221
2025
Q3
$1.74M Buy
124,364
+856
+0.7% +$12.3K 0.1% 119
2025
Q2
$1.86M Sell
123,508
-1,683
-1% -$24K 0.11% 123
2025
Q1
$1.65M Sell
125,191
-16,711
-12% -$231K 0.12% 104
2024
Q4
$2.24M Buy
141,902
+1,317
+0.9% +$19.8K 0.14% 121
2024
Q3
$2.23M Sell
140,585
-9,120
-6% -$147K 0.14% 124
2024
Q2
$2.28M Buy
149,705
+5,405
+4% +$77.5K 0.15% 120
2024
Q1
$2.12M Sell
144,300
-32,440
-18% -$474K 0.16% 111
2023
Q4
$2.46M Buy
176,740
+20,945
+13% +$280K 0.16% 111
2023
Q3
$2.08M Buy
155,795
+26,095
+20% +$353K 0.14% 126
2023
Q2
$1.64M Buy
129,700
+38,540
+42% +$450K 0.11% 147
2023
Q1
$1.04M Sell
91,160
-685
-0.7% -$7.39K 0.08% 229
2022
Q4
$951K Buy
91,845
+35,980
+64% +$388K 0.08% 201
2022
Q3
$585K Buy
55,865
+17,545
+46% +$187K 0.05% 282
2022
Q2
$425K Buy
38,320
+13,265
+53% +$144K 0.04% 348
2022
Q1
$279K Buy
+25,055
New +$284K 0.02% 420

Other funds holding RDY

Summit Global Investments's RDY Position: Q2 2026 in Review

Summit Global Investments sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 53,845 shares — an estimated $746K sold.

Summit Global Investments first reported a position in RDY in Q1 2022 and held it in 17 quarters. The position peaked at $2.46M in Q4 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Summit Global Investments reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • Summit Global Investments sold 53,845 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $746K.
  • Summit Global Investments first reported a position in Dr. Reddy's Laboratories in Q1 2022 and held it in 17 quarters.
  • Summit Global Investments's Dr. Reddy's Laboratories position peaked at $2.46M in Q4 2023.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.